Published annually, volumes in this series provide readers with
updates of recent clinical trial results, impacts of trials on
guidelines and evidence-based practice, advances in trial
methodologies, and the evolution of biomarkers in trials. The
series focuses on trials in neurotherapeutics, including
disease-modifying and symptomatic agents for neurological diseases,
psychopharmacological management of neurologic and psychiatric
illnesses, and non-drug treatments. Each paper is authored by a
leader in the area of neurotherapeutics and clinical trials, and
the series is guided by an editor-in-chief and editorial board with
broad experience in drug development and neuropsychopharmacology.
Progress in Neurotherapeutics and Neuropsychopharmacology" is an
essential update of recent trials in all aspects of the management
of neurologic and neuropsychiatric disorders, and will be an
invaluable resource for practicing neurologists as well as clinical
and translational neuroscientists.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!